June 14, 2021

Isofol raises SEK 500 million in oversubscribed rights issue and exercised over-allotment option

Link to the press release >>

March 19, 2021

Isofol receives recommendation from iDSMB to complete the AGENT study for market registration as planned with 440 patients

Link to the press release >>

See how arfolitixorin
works in cancer cells

See the animation >>

Previous

Next

Startpage 2

Press releases & Latest news

Bulletin from Annual General Meeting in Isofol Medical AB (publ) held on June 23, 2021

Bulletin from Annual General Meeting in Isofol Medical AB (publ) held on June 23, 2021

June 23, 2021 by

Today on June 23, 2021 in Gothenburg – Isofol Medical AB (publ), (Nasdaq First North Premier Growth Market: ISOFOL), held…

Isofol raises SEK 500 million in oversubscribed rights issue and exercised over-allotment option

Isofol raises SEK 500 million in oversubscribed rights issue and exercised over-allotment option

June 14, 2021 by Admin Isofol

GOTHENBURG, Sweden, June 14, 2021 - Isofol Medical AB (publ) (Nasdaq First North Premier Growth Market: ISOFOL) (“Isofol” or the…

Interview with Isofol´s CEO made by Pareto Securities

Interview with Isofol´s CEO made by Pareto Securities

June 8, 2021 by Admin Isofol

See the interview with our CEO, Ulf Jungnelius, that was made by Pareto Securities, in connection to the announced rights…

Upcoming Events

August 24, 2021 - August 24, 2021
Interim Report Q2 2021
September 01, 2021 - September 01, 2021
Pareto Securities´ Healthcare Conference, Stockholm
September 06, 2021 - September 17, 2021
LSX Nordic Congress Virtual Showcase
November 15, 2021 - November 15, 2021
Interim Report Q3 2021

©2019 Isofol Medical AB (publ) Biotech Center, Arvid Wallgrens Backe 20, SE-413 46 Gothenburg, Sweden.

Isofol´s Glossary

Isofol's website uses cookies to improve and customize your visit. By continuing you accept this.Accept Read More
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are as essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.

Necessary
Necessary
Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

SAVE & ACCEPT